Regulation of thrombomodulin expression in human vascular smooth muscle cells by COX-2–derived prostaglandins
K Rabausch, E Bretschneider, M Sarbia… - Circulation …, 2005 - Am Heart Assoc
There is concern that cyclooxygenase (COX)-2 inhibitors may promote atherothrombosis by
inhibiting vascular formation of prostacyclin (PGI2) and an increased thrombotic risk of COX …
inhibiting vascular formation of prostacyclin (PGI2) and an increased thrombotic risk of COX …
Salvianolic acid B attenuates cyclooxygenase‐2 expression in vitro in LPS‐treated human aortic smooth muscle cells and in vivo in the apolipoprotein‐E‐deficient …
YL Chen, CS Hu, FY Lin, YH Chen… - Journal of cellular …, 2006 - Wiley Online Library
Inflammation plays an essential role in atherosclerosis and post‐angioplasty restenosis and
the synthesis and release of inflammatory cytokines from vascular smooth muscle cells is an …
the synthesis and release of inflammatory cytokines from vascular smooth muscle cells is an …
Cyclooxygenase-1 Is Involved in Endothelial Dysfunction of Mesenteric Small Arteries From Angiotensin II–Infused Mice
Angiotensin II induces endothelial dysfunction by reducing NO availability and increasing
reactive oxygen species. We assessed whether cyclooxygenase (COX)-1 or COX-2 …
reactive oxygen species. We assessed whether cyclooxygenase (COX)-1 or COX-2 …
Atherosclerosis regression and TP receptor inhibition: effect of S18886 on plaque size and composition—a magnetic resonance imaging study
JF Viles-Gonzalez, V Fuster, R Corti… - European heart …, 2005 - academic.oup.com
Aims Endothelial dysfunction, platelet hyperactivity, and inflammation play a crucial role in
atherogenesis. A growing body of evidence suggests that inhibition of the thromboxane A2 …
atherogenesis. A growing body of evidence suggests that inhibition of the thromboxane A2 …
COX-2 suppresses tissue factor expression via endocannabinoid-directed PPARδ activation
M Ghosh, H Wang, Y Ai, E Romeo… - The Journal of …, 2007 - rupress.org
Although cyclooxygenase (COX)-2 inhibitors (coxibs) are effective in controlling
inflammation, pain, and tumorigenesis, their use is limited by the recent revelation of …
inflammation, pain, and tumorigenesis, their use is limited by the recent revelation of …
From endothelium to lipids, through microRNAs and PCSK9: a fascinating travel across atherosclerosis
D D'Ardes, F Santilli, MT Guagnano, M Bucci… - High Blood Pressure & …, 2020 - Springer
Lipids and endothelium are pivotal players on the scene of atherosclerosis and their
interaction is crucial for the establishment of the pathological processes. The endothelium is …
interaction is crucial for the establishment of the pathological processes. The endothelium is …
The cycloxygenase 2 (COX-2) story: it's time to explain, not inflame
G Salinas, UC Rangasetty… - Journal of …, 2007 - journals.sagepub.com
Despite initial promising reports that anti-inflammatory properties of cycloxygenase-2 (COX-
2) inhibitors may confer anti-atherosclerosis effects and stabilize the atherosclerotic plaque …
2) inhibitors may confer anti-atherosclerosis effects and stabilize the atherosclerotic plaque …
Adverse effects of COX‐2 inhibitors
JN Sharma, NM Jawad - The Scientific World Journal, 2005 - Wiley Online Library
Cyclooxygenase‐2 selective inhibitors (COXIBs) were developed with the prime object of
minimizing gastrointestinal adverse effects, which are seen with the use of traditional …
minimizing gastrointestinal adverse effects, which are seen with the use of traditional …
Eicosanoids and the vascular endothelium
K Egan, GA FitzGerald - The Vascular Endothelium I, 2006 - Springer
Cyclooxygenase (COX) enzymes catalyse the biotransformation of arachidonic acid to
prostaglandins which subserve important functions in cardiovascular homeostasis …
prostaglandins which subserve important functions in cardiovascular homeostasis …
Aspirin resistance: current concepts.
PJ Mason, JE Freedman, AK Jacobs - Reviews in cardiovascular …, 2004 - europepmc.org
Aspirin is an effective antiplatelet agent with proven benefit in the prevention of
atherothrombotic complications of cardiovascular disease. The antithrombotic effects of …
atherothrombotic complications of cardiovascular disease. The antithrombotic effects of …